1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [02616c44-bc90-451f-bfc9-ce4a08c8f3d1] => Array
        (
            [runtime-id] => 02616c44-bc90-451f-bfc9-ce4a08c8f3d1
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [6cba0be0-7fb4-4029-ba0e-34cc23f24938] => Array
                        (
                            [runtime-id] => 6cba0be0-7fb4-4029-ba0e-34cc23f24938
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b438aff4de56077130bf8a60f65000d81b9117a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [02616c44-bc90-451f-bfc9-ce4a08c8f3d1] => Array
        (
            [runtime-id] => 02616c44-bc90-451f-bfc9-ce4a08c8f3d1
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [6cba0be0-7fb4-4029-ba0e-34cc23f24938] => Array
                        (
                            [runtime-id] => 6cba0be0-7fb4-4029-ba0e-34cc23f24938
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;b438aff4de56077130bf8a60f65000d81b9117a7
                )

        )

)


Table 1: 
Baseline characteristics of the patients
CEA (n = 23)CAS (n = 44)Medical Treatment (n = 74)P Value
Demographics
 Age (mean) (SD) (yr)68.6 (7.9)68.4 (10.9)69.0 (8.3).946
 Age younger than 65 yr (No.) (%)7 (30.4)13 (29.5)22 (31.1).985
 Age 65–74 yr (No.) (%)9 (39.1)16 (36.4)30 (40.5).904
 Age 75 yr or older (No.) (%)7 (30.4)15 (34.1)21 (28.4).809
 Male sex (No.) (%)19 (82.6)39 (88.6)62 (83.8).723
Time to revascularization
 Days to revascularization, (median) (IQR)22 (11–53)21 (8−39.5).930
 Revascularization within 15 days after the presenting event (No.) (%)8 (34.8)20 (45.5).400
Risk factors
 Hypertension (No.) (%)15 (65.2)35 (79.5)51 (68.9).352
 Diabetes mellitus (No.) (%)10 (43.5)12 (27.3)29 (39.2).311
 Dyslipidemia (No.) (%)13 (56.5)21 (47.7)39 (52.7).770
 Current smoker (No.) (%)9 (39.1)17 (38.6)23 (31.1).629
 Ischemic heart disease (No.) (%)2 (8.7)8 (18.2)13 (17.6).556
 Atrial fibrillation (No.) (%)01 (2.3)6 (8.1).180
 Previous stroke/TIA (No.) (%)a4 (17.4)11 (25)20 (27).646
 Peripheral artery disease (No.) (%)3 (13)5 (11.4)5 (6.8).554
Clinical presentation
 Ipsilateral ischemic stroke or retinal infarct (No.) (%)17 (73.9)31 (70.5)47 (63.5).566
 Ipsilateral transient symptoms (No.) (%)6 (26.1)13 (29.5)27 (36.5).566
 Ipsilateral recurrent events (No.) (%)4 (17.4)7 (15.9)13 (17.6).972
Full collapse (No.) (%)b5 (23.8)10 (33.3)26 (41.3).332
  • ↵a The history of stroke/TIA before the index event.
  • ↵b The presence or absence of full collapse could be determined in 114 patients.